title: Vedolizumab safety in pregnancy and newborn outcomes.
authors.affiliation: Department of Gastroenterology and Hepatology, Aarhus University Hospital, Aarhus C, Denmark.
authors.forename: Mette
authors.initials: M
authors.lastname: Julsgaard
authors.affiliation: Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
authors.forename: Jens
authors.initials: J
authors.lastname: Kjeldsen
authors.affiliation: Department of Gastroenterology and Hepatology, Charité Medical School, Humboldt-University of Berlin, Berlin, Germany.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Baumgart
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D003093:Colitis, Ulcerative; D003424:Crohn Disease; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C543529:vedolizumab
keywords: CROHN'S DISEASE; PHARMACOTHERAPY; ULCERATIVE COLITIS